Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Milestone

So in effect, are you saying that shareholders have missed their opportunity (AGAIN), to submit any proposal, because it should have been done 120 days (approx 4 mos) before Dec. 8, 2010.

Share
New Message
Please login to post a reply